Pulpdent Launches ACTIVA Presto in United States

VERITAS Vision System Is Introduced by Johnson & Johnson

The company will offer live demos of the new system in a wet lab at the Johnson & Johnson booth (#2813) this weekend at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting.

GenesisCare Orders 27 Elekta Flexitron Treatment Devices

"GenesisCare continues to demonstrate its commitment to improving patient outcomes worldwide and Elekta is delighted to play a vital partnering role to achieve this mission," said Gustaf Salford, Elekta's President and CEO.

FoodMarble AIRE Shown to Exceed the Performance of ‘Gold Standard’ SIBO Testing in Clinical Trial

SIBO is a very common disorder where there are excessive bacteria present in the small intestine. The true prevalence of SIBO in the general population is largely unknown, with some studies estimating its occurrence in up to 15% of healthy individuals. It is also largely associated with many other common clinical conditions, including irritable bowel syndrome, where 40-80% of IBS patients have SIBO.

Jan 2, 2020

Pulpdent notes using the tooth as the standard, they have developed a material that is esthetic, high strength and contains no Bis-GMA, no Bisphenol A and no BPA derivatives.

The magic of ACTIVA Presto is in the resin, which is moisture-friendly and facilitates the diffusion of bioavailable calcium, phosphate and fluoride ions. “It’s acting just like a tooth,” explains Larry Clark, Director of Clinical Affairs at Pulpdent, “it’s giving off and taking back ions.” This unique chemistry penetrates and integrates with tooth structure for margin-free adaptation. The material also contains a patented rubberized-resin that absorbs stress and resists wear, fracture, and chipping, even in thin areas on bevel margins.

This versatile material is indicated for all classes of cavities and comes in a variety of shades, including cervical shades A4 and A6, which are ideal for older patients. ACTIVA Presto is highly radiopaque (250%) and comes in easy to use 1.2 mL syringes.

ACTIVA Presto can be purchased through all major dental dealers in the United States.

spot_img

DON'T MISS

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.